1. What Qualifies As a Patentable Composition of Matter
The Patent Act defines patentable subject matter broadly, and compositions of matter have long been recognized as eligible inventions. A composition claim typically covers a mixture, compound, or formulation with specific ingredients in defined proportions or relationships. The composition must demonstrate utility (a real-world benefit or function) and non-obviousness to a person skilled in the art.
Courts and the U.S. Patent and Trademark Office apply a practical utility standard. A new alloy, pharmaceutical formulation, or industrial coating qualifies if it solves a technical problem or provides a measurable advantage over prior art. Purely theoretical or speculative uses do not meet the utility threshold. This is where disputes most frequently arise: whether the claimed benefit is genuine or merely aspirational.
Statutory Requirements under 35 U.S.C. Section 101
Section 101 permits patents for "compositions of matter" among other categories. The statute itself is brief, but case law and Patent Office guidance have refined the boundaries. A composition claim must recite specific ingredients and their structural or functional relationships. Broad, open-ended formulations (e.g., "a mixture comprising X and optionally Y") may face rejection if they lack sufficient specificity or if the range of possible compositions is too expansive.
From a practitioner's perspective, applicants often underestimate the importance of claiming both the composition itself and the technical effect it achieves. A claim that recites only ingredients without explaining why that particular combination matters is vulnerable to rejection as lacking enablement or written description.
Distinguishing Compositions from Other Patent Categories
A composition of matter claim differs fundamentally from a method claim or a device claim. A method patent covers steps or processes, a device patent covers apparatus or structure, and a composition patent protects the substance or mixture regardless of how it is produced. This distinction matters during prosecution and infringement analysis. A competitor may avoid a composition patent by using a different manufacturing route to reach the same final product, but they cannot use that same product without infringing the composition claim.
2. Enablement and Written Description in Composition Claims
Two critical requirements under 35 U.S.C. Section 112 often determine success or failure: enablement and written description. Enablement requires that the patent specification teach a person skilled in the art how to make and use the full scope of the claimed composition. Written description requires that the specification convey to the reader that the inventor possessed the claimed invention as of the filing date.
These requirements intersect with claim scope. A narrow claim reciting a specific formulation (e.g., "a composition comprising 10% to 15% compound A and 5% to 8% compound B") is easier to support than a broad claim covering "a composition comprising compound A and compound B in any ratio." Patent examiners scrutinize whether the specification provides sufficient guidance across the entire claimed range.
Common Pitfalls in Specification Drafting
Applicants frequently draft specifications that describe only one or two exemplary formulations without explaining the underlying principles that would guide a skilled artisan in making variations. Courts have held that a specification must enable the full scope of the claims, not just the examples provided. If a claim covers a range of 5% to 50% of an active ingredient but the specification only describes 10% to 20%, enablement issues arise.
In practice, a well-drafted specification includes functional data (e.g., viscosity, melting point, bioavailability) that demonstrates how the composition achieves its utility. Comparative examples showing the claimed composition outperforming prior art formulations strengthen both enablement and non-obviousness arguments.
3. Overcoming Obviousness Rejections in Patent Prosecution
Obviousness remains the most common ground for rejection of composition claims. Under 35 U.S.C. Section 103, an invention is obvious if the differences between the claimed composition and prior art would have been obvious to a person skilled in the art. Patent examiners apply a framework considering the scope and content of prior art, the level of ordinary skill, and secondary considerations, such as commercial success or industry recognition.
Composition claims face particular scrutiny when prior art references teach similar ingredients or formulations. The examiner may argue that combining known components in predictable ratios is obvious. Applicants must rebut this by demonstrating unexpected results, synergistic effects, or a technical problem that the prior art did not address. For pharmaceutical compositions, clinical or pharmacokinetic data showing superior efficacy or reduced side effects can overcome obviousness rejections.
Strategic Use of Dependent and Independent Claims
Experienced practitioners draft a portfolio of claims with varying scope. A broad independent claim reciting the composition in general terms serves as a fallback; narrower dependent claims recite specific ingredient ranges, preferred ratios, or functional properties. This tiered approach allows examiners to grant some claims while narrowing others during prosecution, and it preserves options for post-grant proceedings or litigation.
Consider also whether patent and data rights strategies complement composition protection. Trade secret protection may be preferable for manufacturing parameters or formulation know-how not disclosed in the patent.
4. Enforcement and Infringement Analysis in New York Courts
Composition patent infringement claims filed in federal court (including the U.S. District Court for the Southern District of New York) require proof that an accused product contains each element of the claimed composition. The accused product need not be identical in every detail; it must fall within the scope of the claim as written and as construed by the court.
Claim construction, or "Markman" proceedings, determine the meaning of claim terms before trial. In composition claims, disputes often center on the meaning of ranges, functional language (e.g., "effective amount," "sufficient to"), or structural descriptors. New York federal courts apply the standard that claim terms are construed according to their ordinary and customary meaning as understood by a person skilled in the art, unless the specification provides a different definition.
Practical Considerations for Litigation in Federal Court
Infringement litigation involving composition patents typically requires expert testimony on chemical analysis, formulation science, and equivalents doctrine. The accused product must be reverse-engineered or analyzed to determine its composition. Defendants often challenge infringement by arguing that their formulation falls outside the claim scope or that the claims are invalid for lack of enablement or written description. Civil legal matters involving patent disputes demand early assessment of claim language, prior art risks, and the strength of evidence supporting infringement.
Evaluate whether the composition claims are truly enforceable against competitors' actual products. A claim that is theoretically broad but practically narrow (because competitors use different manufacturing routes or alternative ingredients) may offer less protection than narrower claims that clearly cover market alternatives.
21 Jan, 2026
